The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1019
ISSUE1019
January 30, 1998
Irbesartan for Hypertension
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Irbesartan for Hypertension
January 30, 1998 (Issue: 1019)
Irbesartan (Avapro - Sanofi/Bristol-Myers Squibb) is the third angiotensin II receptor antagonist to become available in the USA for oral treatment of hypertension. Losartan (Cozaar) and valsartan (Diovan) were marketed earlier. Eprosartan (Teveten...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
